Trial Profile
A prospective study to evaluate the relation between changes in foveal choroidal thickness and ranibizumab therapy for polypoidal choroidal vasculopathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 14 Dec 2015 New trial record